Purchase Order 75N95025P00341

This is a $80,400.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Axon Medchem B.V., a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which aims to provide small molecule compounds. The contract has an ultimate completion date of July 25, 2015 and was awarded on April 24, 2015. There was no set-aside designation used for...

This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...

The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...

<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>

This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH &amp; CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...

This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...

<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>

<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>

<p>This is a $460,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Charles River Discovery Research Services UK LIMITED, a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a performance period ending on January 31, 2016. The contract does not have a set-aside designation.</p>

The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of...